Phase 2 Bladder Cancer Trial, Recruiting NCT06528990 Sponsor: City of Hope Medical Center Condition: Bladder Cancer
Back to Bladder Cancer

Phase 2 Bladder Cancer Trial, Recruiting

NCT06528990
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with bladder cancer or colorectal (bowel) cancer
  • You are scheduled to have surgery that will include the creation of a stoma (an opening made in the abdomen to allow waste — either stool or urine — to leave the body through a pouch)
  • If you have bladder cancer, you must be having a specific type of urine stoma called an ileal conduit (where urine drains freely into a pouch rather than being controlled)
  • You are 18 years of age or older
  • You are able to read and understand English well enough to complete questionnaires

Family members or friends (caregivers) may also be able to join if:

  • You are identified by the patient as someone who knows them well and is involved in helping care for them before and after surgery
  • You are 18 years of age or older
  • You are able to read and understand English well enough to complete questionnaires
  • You are pregnant — the trial states this is still allowed, as this type of educational program is not expected to affect a pregnancy

Who may not be able to join:

  • Patients under 18 years of age
  • Patients with bladder cancer who are not having an ileal conduit type of urostomy (confirm with trial site)
  • Anyone — patient or caregiver — who is unable to read and understand English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Virginia Sun, PhD, RN, City of Hope Medical Center

Phone: 626-218-3122

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
2 January 2025
Est. completion
4 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Self-Efficacy for Ostomy Self-Management

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov